Literature DB >> 20225172

Feeding practices and patent ductus arteriosus ligation preferences-are they related?

Nami Jhaveri1, Roger F Soll, Ronald I Clyman.   

Abstract

We hypothesized that there is a significant relationship between a neonatologist's belief that feedings must be stopped in the presence of a patent ductus arteriosus (PDA) and his or her willingness to ligate a PDA. We administered the same survey questionnaire to two separate populations of neonatologists to assess their beliefs regarding PDA treatment practices. Although >90% of U.S. and non-U.S. neonatologists reported that they would ligate a PDA when infants with birth weights <900 g required mechanical ventilation (and indomethacin was contraindicated or had failed to close the PDA), U.S. neonatologists reported that they were significantly more likely to ligate a PDA when less respiratory support was required. U.S. neonatologists were also more likely to stop feedings when a PDA was present. The reported likelihood that a neonatologist would ligate a PDA in infants who did not require mechanical ventilation was significantly increased if the neonatologist believed that feedings had to be stopped because of the PDA. After controlling for the belief that "feedings must be stopped in the presence of a PDA," the significant difference between U.S. and non-U.S. neonatologists, in their reported desire to ligate infants who did not require mechanical ventilation, was no longer present. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225172     DOI: 10.1055/s-0030-1249764

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  9 in total

1.  Enteral feeding during indomethacin treatment for patent ductus arteriosus: association with gastrointestinal outcomes.

Authors:  D Louis; R Torgalkar; J Shah; P S Shah; A Jain
Journal:  J Perinatol       Date:  2016-02-25       Impact factor: 2.521

2.  Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment.

Authors:  Nami Jhaveri; Anita Moon-Grady; Ronald I Clyman
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

Review 3.  Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion; Iris Ambrosio-Perez
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 4.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

5.  Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus.

Authors:  Ronald Clyman; Andrea Wickremasinghe; Nami Jhaveri; Denise C Hassinger; Joshua T Attridge; Ulana Sanocka; Richard Polin; Maria Gillam-Krakauer; Jeff Reese; Mark Mammel; Robert Couser; Neil Mulrooney; Toby D Yanowitz; Matthew Derrick; Priya Jegatheesan; Michele Walsh; Alan Fujii; Nicolas Porta; William A Carey; Jonathan R Swanson
Journal:  J Pediatr       Date:  2013-03-06       Impact factor: 4.406

6.  PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.

Authors:  Ronald I Clyman; Melissa Liebowitz; Joseph Kaempf; Omer Erdeve; Ali Bulbul; Stellan Håkansson; Johanna Lindqvist; Aijaz Farooqi; Anup Katheria; Jason Sauberan; Jaideep Singh; Kelly Nelson; Andrea Wickremasinghe; Lawrence Dong; Denise C Hassinger; Susan W Aucott; Madoka Hayashi; Anne Marie Heuchan; William A Carey; Matthew Derrick; Erika Fernandez; Meera Sankar; Tina Leone; Jorge Perez; Arturo Serize
Journal:  J Pediatr       Date:  2018-10-16       Impact factor: 4.406

7.  Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus.

Authors:  Andrea C Wickremasinghe; Elizabeth E Rogers; Robert E Piecuch; Bridget C Johnson; Suzanne Golden; Anita J Moon-Grady; Ronald I Clyman
Journal:  J Pediatr       Date:  2012-07-13       Impact factor: 4.406

8.  A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants.

Authors:  Khalid AlFaleh; Eman Alluwaimi; Ahlam AlOsaimi; Sheikha Alrajebah; Bashayer AlOtaibi; Fatima AlRasheed; Turki AlKharfi; Bosco Paes
Journal:  BMC Pediatr       Date:  2015-04-22       Impact factor: 2.125

Review 9.  To Feed or Not to Feed: A Critical Overview of Enteral Feeding Management and Gastrointestinal Complications in Preterm Neonates with a Patent Ductus Arteriosus.

Authors:  Silvia Martini; Arianna Aceti; Silvia Galletti; Isadora Beghetti; Giacomo Faldella; Luigi Corvaglia
Journal:  Nutrients       Date:  2019-12-27       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.